| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |